Patient Engagement May Help Prevent Drug Interactions, Related Opioid Overdoses

Tabula Rasa HealthCare’s Jacques Turgeon, BPharm, PhD, Chief Scientific Officer and CEO, TRHC Precision Pharmacotherapy Research and Development Institute is featured in Pharmacy Times. Turgeon discusses research related to drug interactions and how pharmacists’ engagement with patients can promote medication safety.